Search Results - "Hargreaves, Anita"

Intra-operative guidance: Methods for achieving negative margins in breast conserving surgery by Hargreaves, Anita C., Mohamed, Mohamed, Audisio, Riccardo A.

“…The increasing incidence of breast cancer and advances in detection of small, impalpable cancers presents increasing challenges for the modern breast surgeon…”
Get full text

P081. A breast shield clinic - protecting the vulnerable from COVID 19 and cancer by Foster, Rachel, Ooi, Jane, Hargreaves, Anita

Get full text

Completion mastectomy after wide local excision (WLE) and sentinel lymph node biopsy (SLNB) for ductal carcinoma in situ (DCIS), local data from the countess of Chester hospital by Abdelmageed, Ahmed, Hargreaves, Anita, Ooi, Jane, Harding-Mackean, Claudia, Seward, Joanna, Marikakis, Nikolaos

Get full text

Radiation dose exposure during sentinel lymph node biopsy by Hargreaves, Anita, Scott, Tracy, Poonawala, Shabbir

Get full text

Does the use of a bio-impedence device reduce the need for re-operation in breast conserving surgery? A pilot study by Hargreaves, Anita, Sridharan, Uma, Mitchell, Geraldine

Get full text

Current axillary management of patients with early breast cancer and low-volume nodal disease undergoing primary surgery: results of a United Kingdom national practice survey by Fairhurst, K., McIntosh, S. A., Cutress, R. I., Potter, S.

“…Purpose UK NICE guidelines recommend axillary node clearance (ANC) should be performed in all patients with biopsy-proven node-positive breast cancer having…”
Get full text

Current use of drains and management of seroma following mastectomy and axillary surgery: results of a United Kingdom national practice survey by Fairhurst, K., Roberts, K., Fairbrother, P., Potter, S.

“…Purpose Up to 40% of the 56,000 women diagnosed with breast cancer each year in the UK undergo mastectomy. Seroma formation following surgery is common, may…”
Get full text

Abstract PO3-01-13: A study of the impact of the implementation of the Oncotype Dx 21-gene breast-cancer assay during the SARS-CoV-2 pandemic for 1-3 node positive early breast cancer: The Clatterbridge Cancer Centre Experience by Johnson, Alexandra, Bathla, Sonia, Chagla, Leena, Cliff, Joanne, Hall, Allison, Hargreaves, Anita, Hart, Clare, Malik, Zafar, Roshanlall, Chandeena, Sripadam, Raj, Palmieri, Carlo, Innes, Helen

“…Background: The 21-gene breast cancer (BC) assay (Oncotype Dx) is used to predict chemotherapy benefit in ER+, HER-2- lymph node (LN) negative BC. The RxPONDER…”
Get full text

Can we predict further axillary nodal disease in patients with sentinel node macro metastases by OSNA in early breast cancer? by Sridharan, Uma, Hargreaves, Anita, McKenna, Adrian, Potter, Shelley, Lennon, Hannah, Eley, Catherine, Holcombe, Chris, Mitchell, Geraldine

Get full text

Is clinical examination becoming obsolete in modern surgical practice? by Hancorn, Kate, Hargreaves, Anita, Wellens, Tom, Heneghan, Sinead, Rajaganeshan, Rajasundaram

Get full text

Correlation and diagnostic accuracy of CT in the acute surgical presentation by Hargreaves, Anita, Hancorn, Kate, Mohamed, Mohamed, Wellens, Tom, Heneghan, Sinead

Get full text